| Name | Title | Contact Details |
|---|
Otava is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Eastern Area Specialty Transport is a Winchester, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
LA Marquise-Texas is a Deer Park, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
It`s good to be home! Jet Health is a provider of skilled home health, hospice, personal care, and companion services. Founded in April 2016, Jet Health is building a national platform through organic growth, strategic acquisitions, and de novo build-outs in target markets. These markets are typically mid-sized cities that have under served and growing Medicare populations. Jet Health leverages local brands and operating expertise while sharing best practices across its companies and centralizes traditional back office functions. The company believes that its four cornerstones: superior service, clinical excellence, compliant business practices and an employee centric environment, provide a solid foundation upon which to build a successful company in the home health marketplace.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.